<DOC>
	<DOCNO>NCT02552628</DOCNO>
	<brief_summary>Dystonia Wilson 's disease represent major issue . The persistence disable motor symptom despite medical treatment justifies conduct study deep brain stimulation ( DBS ) Wilson 's disease ( WD ) . For bradykinetic patient , subthalamic nucleus ( STN ) could consider well target globus pallidus ( GPi ) . For patient hyperkinetic dystonia , internal globus pallidus ( GPi ) choose target DBS . The investigator hypothesize STN DBS improve Wilson 's disease patient , , despite copper chelators drug , still impair severe dystonia akinesia ( less associate movement disorder ) . The investigator primary objective demonstrate efficacy STN/GPi DBS dystonia associate Wilson 's disease . Secondary objective : - To evaluate impact STN/GPi DBS movement disorder ( tremor , Parkinsonism , chorea ) observe Wilson 's disease . - To describe cognitive status patient evaluate consequence STN/GPi DBS cognition behavioral aspect disease . - To evaluate consequence stimulation speech swallow . - To evaluate social impact STN/GPi DBS Wilson 's disease . - To evaluate safety STN/GPi DBS specific context Wilson 's disease .</brief_summary>
	<brief_title>WILSTIM - DBS ( WILson STIMulation - Deep Brain Stimulation )</brief_title>
	<detailed_description>4 period stimulation , sequence randomize Day 0 .</detailed_description>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Hepatolenticular Degeneration</mesh_term>
	<criteria>Age &gt; 18 &lt; 60 year . Severe neurological form Wilson 's disease predominant dystonia akineticrigid syndrome , despite optimize treatment stabilize least 6 month . Important disability due abnormal movement ( Rankin score=2 4 ) . Absence dementia ( MMS &gt; 24 BREF &gt; 15 ) . Stable psychiatric status absence severe depression ( BDI &lt; 28 ) . Social security coverage . Signature informed consent . ( signature legal guardian subject protection ) Severe hepatopathy coagulation disorder ( Platelet count &lt; 100 G / l ; INR &gt; 1.5 ; V factor deficit ; low level fibrinogen &lt; 1g/dL ; increase fibrin degradation product ; low level antithrombin ) . Liver transplant patient patient immunosupressive drug . Participation another biomedical research involve drug . Severe uncontrolled psychosis depression . Major atrophy brain MRI could represent problem lead implantation . Necrosis STN/GPi brain MRI . Female subject pregnant lactating .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Wilson 's Disease</keyword>
	<keyword>Deep Brain Stimulation</keyword>
	<keyword>dystonia</keyword>
</DOC>